Showing posts with label Regenerative Medicine. Show all posts
Showing posts with label Regenerative Medicine. Show all posts

Monday, 28 May 2018

Technological Advancements: Global Regenerative Medicine Sales Market 2025 | Athersys Inc, Amgen Inc, Bioheart Inc, Cytori Therapeutics Inc and Others

Researchmoz added Most up-to-date research on "Global Regenerative Medicine Sales Market Report 2018" to its huge collection of research reports.

In this report, the global Regenerative Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Regenerative Medicine for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1674162

Global Regenerative Medicine market competition by top manufacturers/players, with Regenerative Medicine sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Aastrom Biosciences Inc
Advanced Cell Technology
Athersys Inc
Amgen Inc
Bioheart Inc
Cytori Therapeutics Inc
Celgene Corporation
Geron Corporation
Genzyme Corporation
Osiris Therapeutics Inc
Japan Tissue Engineering Co
Thermogenesis Corp
Mesoblast, Inc
Vertex Pharmaceuticals, Inc
Organogenesis, Inc
Nuvasive, Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cell Therapy (Ct) Based Products
Tissue Engineered (Te) Products
Bone and Cartilage Grafting and Regenerative Products
Electrical Stimulators
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Bone And Joints Replacement
Dental
Neurological
Organ Regeneration
Cardiovascular Disorders
Wound Care
Others

Table of Contents

Global Regenerative Medicine Sales Market Report 2018
1 Regenerative Medicine Market Overview
1.1 Product Overview and Scope of Regenerative Medicine
1.2 Classification of Regenerative Medicine by Product Category
1.2.1 Global Regenerative Medicine Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Regenerative Medicine Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Cell Therapy (Ct) Based Products
1.2.4 Tissue Engineered (Te) Products
1.2.5 Bone and Cartilage Grafting and Regenerative Products
1.2.6 Electrical Stimulators
1.2.7 Others
1.3 Global Regenerative Medicine Market by Application/End Users
1.3.1 Global Regenerative Medicine Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Bone And Joints Replacement
1.3.3 Dental
1.3.4 Neurological
1.3.5 Organ Regeneration
1.3.6 Cardiovascular Disorders
1.3.7 Wound Care
1.3.8 Others
1.4 Global Regenerative Medicine Market by Region
1.4.1 Global Regenerative Medicine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Regenerative Medicine Status and Prospect (2013-2025)
1.4.3 China Regenerative Medicine Status and Prospect (2013-2025)
1.4.4 Europe Regenerative Medicine Status and Prospect (2013-2025)
1.4.5 Japan Regenerative Medicine Status and Prospect (2013-2025)
1.4.6 Southeast Asia Regenerative Medicine Status and Prospect (2013-2025)
1.4.7 India Regenerative Medicine Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Regenerative Medicine (2013-2025)
1.5.1 Global Regenerative Medicine Sales and Growth Rate (2013-2025)
1.5.2 Global Regenerative Medicine Revenue and Growth Rate (2013-2025)

2 Global Regenerative Medicine Competition by Players/Suppliers, Type and Application
2.1 Global Regenerative Medicine Market Competition by Players/Suppliers
2.1.1 Global Regenerative Medicine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Regenerative Medicine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Regenerative Medicine (Volume and Value) by Type
2.2.1 Global Regenerative Medicine Sales and Market Share by Type (2013-2018)
2.2.2 Global Regenerative Medicine Revenue and Market Share by Type (2013-2018)
2.3 Global Regenerative Medicine (Volume and Value) by Region
2.3.1 Global Regenerative Medicine Sales and Market Share by Region (2013-2018)
2.3.2 Global Regenerative Medicine Revenue and Market Share by Region (2013-2018)
2.4 Global Regenerative Medicine (Volume) by Application

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-regenerative-medicine-sales-market-report-2018-report.html/toc

3 United States Regenerative Medicine (Volume, Value and Sales Price)
3.1 United States Regenerative Medicine Sales and Value (2013-2018)
3.1.1 United States Regenerative Medicine Sales and Growth Rate (2013-2018)
3.1.2 United States Regenerative Medicine Revenue and Growth Rate (2013-2018)
3.1.3 United States Regenerative Medicine Sales Price Trend (2013-2018)
3.2 United States Regenerative Medicine Sales Volume and Market Share by Players (2013-2018)
3.3 United States Regenerative Medicine Sales Volume and Market Share by Type (2013-2018)
3.4 United States Regenerative Medicine Sales Volume and Market Share by Application (2013-2018)

4 China Regenerative Medicine (Volume, Value and Sales Price)
4.1 China Regenerative Medicine Sales and Value (2013-2018)
4.1.1 China Regenerative Medicine Sales and Growth Rate (2013-2018)
4.1.2 China Regenerative Medicine Revenue and Growth Rate (2013-2018)
4.1.3 China Regenerative Medicine Sales Price Trend (2013-2018)
4.2 China Regenerative Medicine Sales Volume and Market Share by Players (2013-2018)
4.3 China Regenerative Medicine Sales Volume and Market Share by Type (2013-2018)
4.4 China Regenerative Medicine Sales Volume and Market Share by Application (2013-2018)

5 Europe Regenerative Medicine (Volume, Value and Sales Price)
5.1 Europe Regenerative Medicine Sales and Value (2013-2018)
5.1.1 Europe Regenerative Medicine Sales and Growth Rate (2013-2018)
5.1.2 Europe Regenerative Medicine Revenue and Growth Rate (2013-2018)
5.1.3 Europe Regenerative Medicine Sales Price Trend (2013-2018)
5.2 Europe Regenerative Medicine Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Regenerative Medicine Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Regenerative Medicine Sales Volume and Market Share by Application (2013-2018)

6 Japan Regenerative Medicine (Volume, Value and Sales Price)
6.1 Japan Regenerative Medicine Sales and Value (2013-2018)
6.1.1 Japan Regenerative Medicine Sales and Growth Rate (2013-2018)
6.1.2 Japan Regenerative Medicine Revenue and Growth Rate (2013-2018)
6.1.3 Japan Regenerative Medicine Sales Price Trend (2013-2018)
6.2 Japan Regenerative Medicine Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Regenerative Medicine Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Regenerative Medicine Sales Volume and Market Share by Application (2013-2018)

Continue...

Wednesday, 23 August 2017

Regenerative Medicine Market In The US To Grow At A CAGR Of 23.53% During The Period 2017-2021 Key Vendors - Acelity, Medtronic, MiMedx, Organogenesis, Zimmer Biomet

Researchmoz added Most up-to-date research on "Regenerative Medicine Market in the US 2017-2021" to its huge collection of research reports.

Regenerative medicine is a bioproduct, which is developed by using translational research techniques such as molecular biology, tissue engineering, and gene engineering. Stem cells and tissue scaffolds have the effective therapeutic potential, which has increased the adoption of regenerative medicine in the US market. Stem cell therapy responds well to various treatments such as dermatological, macular, musculoskeletal, and cardiovascular applications. The regenerative medicine industry includes four key sectors, which help the vendors to develop regenerative medicine.

Technavios analysts forecast the Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1267270

Covered in this report
The report covers the present scenario and the growth prospects of the Regenerative Medicine Market in the US for 2017-2021. To calculate the market size, the report considers the sales, volume, and value of regenerative medicine market in the US.

Regenerative Medicine Market in the US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Acelity
Medtronic
MiMedx
Organogenesis
Zimmer Biomet

Browse Detail Report With Full TOC @ http://www.researchmoz.us/regenerative-medicine-market-in-the-us-2017-2021-report.html

Other prominent vendors
ACE Surgical Supply
Acera Surgical
Acologix
Advanced Biologics
AlloCure
AlloSource
Alphatec Spine
ANTEROGEN
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bacterin International
Baxter
Bellicum Pharmaceuticals
BioCardia
Biogen
BioRestorative Therapies
Biostage
Bio-Tissue
BioTissue
bluebird bio
BONESUPPORT
BrainStorm Cell Therapeutics
Caladrius
Calimmune
Capricor Therapeutics
CELGENE
Cell Medica
Cell Therapy
CellBioMed
CellSeed
Celyad
CESCA THERAPEUTICS
CTM CRC
CryoLife
Cynata
Cytori Therapeutics
Dendreon Pharmaceuticals
DiscGenics
Fate Therapeutics
Fibrocell Science
Forticell Bioscience
Fortress Biotech
FUJIFILM Holdings
Gamida Cell
Geron
GlaxoSmithKline
Healthpoint (acquired by Smith & Nephew)
Histogen
Histogenics
Holostem Terapie Avanzate
Humacyte
Immunocellular Therapeutics
Integra LifeSciences
Intercytex
InVivo Therapeutics
iSTO Biologics
Janssen Pharmaceuticals
Juno Therapeutics
Juventas Therapeutics
Kiadis Pharma
LifeCell
LifeNet Health
Living Cell Technologies
Lonza
MaxCyte
MEDIPOST
Mesoblast
Nanofiber Solutions
Nanotope
Neuralstem
NewLink Genetics
Northwest Biotherapeutics
NovaRx
Opexa Therapeutics
ORGANOVO HOLDINGS
Orteq
Orthofix Holdings
Osiris Therapeutics
Pfizer
PHARMICELL
Pluristem
Prima BioMed
Q Therapeutics
Regenerex
Regenerys
Regience
Regrow
RENOVA THERAPEUTICS
RepliCel
ReproCELL
RhinoCyte
Rohto Pharma
RTI Surgical
SanBio
Sangamo Therapeutics
Shanghai Sunway Biotech
Shire
Stratatech
SURGILOGIX
Synergistic Technologies
TAKARA BIO
tella
Tissue Genesis
TissueGene
Txcell
VentriNova
Vericel
ViaCyte
VistaGen Therapeutics

Market driver
CVD and diabetes in young adult and aging population
For a full, detailed list, view our report

Market challenge
High cost of clinical trial
For a full, detailed list, view our report

Market trend
Increasing strategic alliances
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1267270

Tuesday, 24 January 2017

Global Regenerative Medicine Industry Will Grow At Steadily A CAGR Of 20.7% During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Regenerative Medicine Market 2016-2020" to its huge collection of research reports.

Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.

Technavios analysts forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020. To calculate the market size, we used the revenue generated from the sales of various types of regenerative medicine products.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=724221

Technavio's report, Global Regenerative Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Acelity
Medtronic
MiMedx Group
Organogenesis
UniQure
Zimmer Biomet

Other prominent vendors
ACE Surgical Supply
Acologix
Advanced Biologics
AlloCure
Allosource
Alphatec Spine
Altrika
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bacterin International
Baxter
Bellicum Pharmaceuticals
BioCardia
Biogen Idec
BioRestorative Therapies
Biostage Technologies
Bluebird Bio
BONESUPPORT
BrainStorm Cell Therapeutics
Caladrius Biosciences
Calimmune
Capricor Therapeutics
Celgene
Cell Medica
CellSeed
Cell Therapy
Celyad
CESCA THERAPEUTICS
CRC for Cell Therapy Manufacturing
Cryolife
Cynata Therapeutics
Cytori Therapeutics
Dendreon
DiscGenics
Fate Therapeutics
Fibrocell Science
Forticell Bioscience
Fortress Biotech
FUJIFILM
Gamida Cell
Geron
GlaxoSmithKline
Healthpoint
Histogen
Histogenics
Holostem Terapie Avanzate
Humacyte
ImmunoCellular Therapeutics
Integra LifeSciences
Intercytex
InVivo Therapeutics
iSTO Technologies
Janssen Pharma
Juno Therapeutics
Juventas Therapeutics
Kensey Nash
Kiadis Pharma
Kinetic Concept
LifeCell
LifeNet Health
Living Cell Technologies
Lonza
MaxCyte
MEDIPOST
Mesoblast
Nanofiber Solutions CTO
Nanotope
NeoStem
Neuralstem
Newlink Genetics
Northwest Biotherapeutics
NovaRx
Ocata Therapeutics
Opexa Therapeutics
Organovo Holdings
Orteg
Orthofix
Osiris Therapeutics
Osteotech
Pfizer
Pharmicell
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
Regenerex
Regenerys
Regience
Regrow
Replicel
ReproCELL
Renova Therapeutics
RhinoCyte
Rohto Pharmaceutical
RTI Surgical
SanBio
Sangamo BioSciences
Shanghai Sunway Biotech
Shire Regenerative Medicine
StemCells
Stratech
Takara Bio
TEI Biosciences
tella
Tengion
Tissue Genesis
TissueGene
Txcell
VentriNova
Vericel
ViaCyte
Vistagen

Market driver
Increased focus on cell therapy products
For a full, detailed list, view our report

Market challenge
High cost and failure rate in clinical trials
For a full, detailed list, view our report

Market trend
Increased number of regenerative medicine in product line
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=724221

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...